<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04900532</url>
  </required_header>
  <id_info>
    <org_study_id>Denise Mafra</org_study_id>
    <nct_id>NCT04900532</nct_id>
  </id_info>
  <brief_title>Effects of Supplementation With Tocotrienol on Chronic Kidney Disease Patients</brief_title>
  <official_title>Effects of Supplementation With Tocotrienol on Inflammation, Oxidative Stress and Microbiota of Chronic Kidney Disease Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal Fluminense</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wayne State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Federal Fluminense</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the supplementation with tocotrienol, a vitamin E&#xD;
      compound on inflammation, oxidative stress, and microbiota on Chronic Kidney Disease&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In Chronic Kidney Disease (CKD), inflammation and oxidative stress are common statuses, which&#xD;
      are aggravated by renal replacement therapy such as hemodialysis. Currently, intestinal&#xD;
      microbiota imbalance has been associated with both inflammation and oxidative stress. In this&#xD;
      regard, strategies in the management of this framework are necessary. It has been observed&#xD;
      that vitamin E plays an important role in the modulation of transcription factors involved in&#xD;
      inflammation such as NF-kB and Nrf2, acting on cell membrane protection and tissue recovery.&#xD;
      Its benefits have been proven both in renal and intestinal health, however, studies analyzing&#xD;
      the vitamin E supplementation in the modulation of intestinal microbiota with consequent&#xD;
      effect on CKD and its reflexes are scarce. Thus, the current randomized, double-blind,&#xD;
      placebo-controlled study will evaluate the effects of vitamin E supplementation on the&#xD;
      modulation of the expression of nuclear cytokine (NF-kB e Nrf2), activators and inhibitors,&#xD;
      as well as, on inflammation and oxidative stress and on the modulation of the intestinal&#xD;
      microbiota in patients CKD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Actual">August 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Antioxidants and anti-inflammatory biomarkers</measure>
    <time_frame>4 weeks</time_frame>
    <description>Get blood samples to evaluate the supplementation effects in antioxidants biomarkers- nuclear receptor factor 2 (Nrf2), glutathioneperoxidase (GPx), heme oxygenase-1 (HO-1).&#xD;
glutathione peroxidase (GPx), heme oxygenase-1 (HO-1) and microbiota composition from patients feces DNA uremic toxins</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammatory biomarkers</measure>
    <time_frame>4 weeks</time_frame>
    <description>Get blood samples to evaluate the supplementation effects in inflammatory biomarkers- factor nuclear kappa B (NFkB), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Chronic Kidney Diseases</condition>
  <condition>Hemodialysis</condition>
  <condition>Microbiota</condition>
  <condition>Oxidative Stress</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Effects of supplementation with tocotrienol on chronic kidney disease patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of tocotrienol-rich-fraction (TRF) capsules, containing 360mg of tocotrienol and 80mg of tocopherol twice a day for six months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Effects of supplementation with tocotrienol on lipid profile of chronic kidney disease patients</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administration of placebo containing 0,96mg of tocotrienol and 1,76mg of tocopherol twice a day for three months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Tocotrienol rich fraction</intervention_name>
    <description>Supplementation with a Vitamin E compound.</description>
    <arm_group_label>Effects of supplementation with tocotrienol on chronic kidney disease patients</arm_group_label>
    <arm_group_label>Effects of supplementation with tocotrienol on lipid profile of chronic kidney disease patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronic kidney disease&#xD;
&#xD;
          -  Aged from 18 to 60 years&#xD;
&#xD;
          -  Must be able to swallow capsules&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant patients&#xD;
&#xD;
          -  Smokers&#xD;
&#xD;
          -  Using antibiotics in the last 3 months&#xD;
&#xD;
          -  Using antioxidant supplements in the last 3 months&#xD;
&#xD;
          -  Usual intake Autoimmune&#xD;
&#xD;
          -  Hemodialysis started less than 6 months for hemodialysis patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Denise Mafra</name>
      <address>
        <city>Rio de Janeiro</city>
        <state>RJ</state>
        <zip>22260050</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2021</study_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

